Cannell Capital - GAIN THERAPEUTICS INC ownership

GAIN THERAPEUTICS INC's ticker is GANX and the CUSIP is 36269B105. A total of 23 filers reported holding GAIN THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.

Quarter-by-quarter ownership
Cannell Capital ownership history of GAIN THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$59,628
+54.0%
12,3710.0%0.01%
+50.0%
Q4 2022$38,721
-3.2%
12,3710.0%0.01%
-11.1%
Q3 2022$40,000
+300.0%
12,371
+349.7%
0.01%
+350.0%
Q2 2022$10,0002,7510.00%
Other shareholders
GAIN THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
CM Management, LLC 90,000$295,2000.31%
Greenlight Capital 588,410$1,929,9850.11%
PRELUDE CAPITAL MANAGEMENT, LLC 58,100$190,5680.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 46,100$148,9030.00%
Householder Group Estate & Retirement Specialist, LLC 2,500$8,2000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
HM PAYSON & CO 1,000$3,2800.00%
GROUP ONE TRADING, L.P. 1,937$6,2570.00%
GEODE CAPITAL MANAGEMENT, LLC 151,476$489,3550.00%
MORGAN STANLEY 1,300$4,2640.00%
View complete list of GAIN THERAPEUTICS INC shareholders